価格表

在庫・価格 : 2024年06月03日 06時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
VEGF, Human, ELISA Kit, QuantiGlo, 2nd Generation (96 well)
データシート
QVE00B RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥135,000
(未発注)
追加

在庫・価格 : 2024年06月03日 06時43分 現在

VEGF, Human, ELISA Kit, QuantiGlo, 2nd Generation (96 well)

  • 商品コード:QVE00B
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥135,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Li H et al. Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2005 Jun;14(6):1557-61
Li H et al
2005/01/01
Sample Type: Plasma (Not Specified) PubMed
2 Christensen JG et al. Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Mol. Cancer Ther. 2005 Jun;4(6):938-47
Christensen JG et al
2005/01/01
Xenograft human tumor and human plasma (heparin) PubMed
3 Li L et al. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res. 2005 Aug;65(16):7249-58
Li L et al
2005/01/01
Sample Type: Homogenized Tissue PubMed
4 Cartwright L et al. Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: pilot study. J Biomed Mater Res A 2006 May;77(2):390-5
Cartwright L et al
2006/01/01
Sample Type: Cell Supernates PubMed
5 Feltis BN et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am. J. Respir. Crit. Care Med. 2006 Jun;173(11):1201-7
Feltis BN et al
2006/01/01
Species: Human, Sample type: BALF PubMed
6 Liu Y et al. Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem. Biophys. Res. Commun. 2006 Jun;344(4):1263-70
Liu Y et al
2006/01/01
Sample Type: Cell Supernates PubMed
7 Carroll VA et al. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway
Carroll VA et al
2006/01/01
Sample Type: Cell Supernates PubMed
8 Sutton KM et al. Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene 2007 Jun;26(27):3920-9
Sutton KM et al
2007/01/01
Species: Human, Sample type: Cell Supernates PubMed
9 Chen Y et al. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J. Biol. Chem. 2007 Nov;282(47):34420-8
Chen Y et al
2007/01/01
Species: Human, Sample type: Cell Supernates PubMed
10 Kut C et al. Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br. J. Cancer 2007 Oct;97(7):978-85
Kut C et al
2007/01/01
Species: Human, Sample type: Cell Lysates, Cell Supernates, Plasma (Not Specified), Serum PubMed
11 Anelli V et al. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J. Biol. Chem. 2008 Feb;283(6):3365-75
Anelli V et al
2008/01/01
Species: Human, Application: Cell Supernates PubMed
12 Hennessy BT et al. Pharmacodynamic markers of perifosine efficacy. Clin. Cancer Res. 2007 Dec;13(24):7421-31
Hennessy BT et al
2007/01/01
Sample Type: Cell Supernates PubMed
13 Carroll VA et al. Regulation of angiogenic factors by HDM2 in renal cell carcinoma. Cancer Res. 2008 Jan;68(2):545-52
Carroll VA et al
2008/01/01
Species: Human, Sample type: Cell Supernates PubMed
14 Etto L et al. Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma. Leuk. Lymphoma 2008 Feb;49(2):257-64
Etto L et al
2008/01/01
Species: Human, Application: Serum PubMed
15 Bendrik C et al. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res. 2008 May;68(9):3405-12
Bendrik C et al
2008/01/01
Species: Human, Application: Homogenized Tissue PubMed
16 Saarinen NM et al. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. Int. J. Cancer 2008 Sep;123(5):1196-204
Saarinen NM et al
2008/01/01
Species: Human, Application: Cell Supernates PubMed
17 Chambers SK et al. Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clin. Cancer Res. 2010 Nov;16(21):5320-8
Chambers SK et al
2010/01/01
Sample Type: Urine PubMed
18 Gupta PK et al. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. J Neuroinflammation 2011;8:47
Gupta PK et al
2011/01/01
Sample Type: CSF PubMed
19 Leifler KS et al. Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer. J. Immunol. 2013 Apr;190(8):4420-30
Leifler KS et al
2013/01/01
Sample Type: Homogenized Tissue PubMed
20 Abu El-Asrar AM et al. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res 2013;2013:539658
Abu El-Asrar AM et al
2013/01/01
Sample Type: Cell Lysates PubMed
21 Lecce L et al. Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesis. Mol. Endocrinol. 2014 Sep;28(9):1487-501
Lecce L et al
2014/01/01
Sample Type: cell supernates PubMed
22 Bader AM et al. Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro. PLoS ONE 2015;10(9):e0138477
Bader AM et al
2015/01/01
Sample Type: Cell Culture Supernates PubMed
23 Xie M et al. MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer. Gastric Cancer 2018 Jan;21(1):41-54
Xie M et al
2018/01/01
PubMed
24 Abrahamsson A et al. Downregulation of tumor suppressive microRNAs <i>in vivo</i> in dense breast tissue of postmenopausal women. Oncotarget 2017 Nov;8(54):92134-92142
Abrahamsson A et al
2017/01/01
PubMed
  • No.: 1
  • 文献情報:
    Li H et al. Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2005 Jun;14(6):1557-61
    Li H et al
    2005/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Christensen JG et al. Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Mol. Cancer Ther. 2005 Jun;4(6):938-47
    Christensen JG et al
    2005/01/01
  • 備考:
    Xenograft human tumor and human plasma (heparin)
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Li L et al. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res. 2005 Aug;65(16):7249-58
    Li L et al
    2005/01/01
  • 備考:
    Sample Type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Cartwright L et al. Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: pilot study. J Biomed Mater Res A 2006 May;77(2):390-5
    Cartwright L et al
    2006/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Feltis BN et al. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am. J. Respir. Crit. Care Med. 2006 Jun;173(11):1201-7
    Feltis BN et al
    2006/01/01
  • 備考:
    Species: Human, Sample type: BALF
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Liu Y et al. Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem. Biophys. Res. Commun. 2006 Jun;344(4):1263-70
    Liu Y et al
    2006/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Carroll VA et al. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway
    Carroll VA et al
    2006/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Sutton KM et al. Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1. Oncogene 2007 Jun;26(27):3920-9
    Sutton KM et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Chen Y et al. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization. J. Biol. Chem. 2007 Nov;282(47):34420-8
    Chen Y et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kut C et al. Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br. J. Cancer 2007 Oct;97(7):978-85
    Kut C et al
    2007/01/01
  • 備考:
    Species: Human, Sample type: Cell Lysates, Cell Supernates, Plasma (Not Specified), Serum
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Anelli V et al. Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J. Biol. Chem. 2008 Feb;283(6):3365-75
    Anelli V et al
    2008/01/01
  • 備考:
    Species: Human, Application: Cell Supernates
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Hennessy BT et al. Pharmacodynamic markers of perifosine efficacy. Clin. Cancer Res. 2007 Dec;13(24):7421-31
    Hennessy BT et al
    2007/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Carroll VA et al. Regulation of angiogenic factors by HDM2 in renal cell carcinoma. Cancer Res. 2008 Jan;68(2):545-52
    Carroll VA et al
    2008/01/01
  • 備考:
    Species: Human, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Etto L et al. Clinical correlations and prognostic relevance of HGF, VEGF AND FGF expression in Brazilian patients with non-Hodgkin lymphoma. Leuk. Lymphoma 2008 Feb;49(2):257-64
    Etto L et al
    2008/01/01
  • 備考:
    Species: Human, Application: Serum
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Bendrik C et al. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo. Cancer Res. 2008 May;68(9):3405-12
    Bendrik C et al
    2008/01/01
  • 備考:
    Species: Human, Application: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Saarinen NM et al. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats. Int. J. Cancer 2008 Sep;123(5):1196-204
    Saarinen NM et al
    2008/01/01
  • 備考:
    Species: Human, Application: Cell Supernates
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Chambers SK et al. Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clin. Cancer Res. 2010 Nov;16(21):5320-8
    Chambers SK et al
    2010/01/01
  • 備考:
    Sample Type: Urine
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Gupta PK et al. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. J Neuroinflammation 2011;8:47
    Gupta PK et al
    2011/01/01
  • 備考:
    Sample Type: CSF
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Leifler KS et al. Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer. J. Immunol. 2013 Apr;190(8):4420-30
    Leifler KS et al
    2013/01/01
  • 備考:
    Sample Type: Homogenized Tissue
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Abu El-Asrar AM et al. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res 2013;2013:539658
    Abu El-Asrar AM et al
    2013/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Lecce L et al. Aging impairs VEGF-mediated, androgen-dependent regulation of angiogenesis. Mol. Endocrinol. 2014 Sep;28(9):1487-501
    Lecce L et al
    2014/01/01
  • 備考:
    Sample Type: cell supernates
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Bader AM et al. Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro. PLoS ONE 2015;10(9):e0138477
    Bader AM et al
    2015/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Xie M et al. MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer. Gastric Cancer 2018 Jan;21(1):41-54
    Xie M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Abrahamsson A et al. Downregulation of tumor suppressive microRNAs <i>in vivo</i> in dense breast tissue of postmenopausal women. Oncotarget 2017 Nov;8(54):92134-92142
    Abrahamsson A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed